Marian L Evatt
Affiliation: Emory University
- Prevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer diseaseMarian L Evatt
Department of Neurology, Emory University School of Medicine, 1841 Clifton Road NE, Atlanta, GA 30329, USA
Arch Neurol 65:1348-52. 2008..A role for vitamin D deficiency in Parkinson disease (PD) has recently been proposed...
- High prevalence of hypovitaminosis D status in patients with early Parkinson diseaseMarian L Evatt
Department of Neurology, Emory University School of Medicine, 1841 Clifton Rd NE, Atlanta, GA 30329, USA
Arch Neurol 68:314-9. 2011....
- Quetiapine improves psychotic symptoms and cognition in Parkinson's diseaseJorge L Juncos
Neurology Department, Emory University, Atlanta, Georgia 30329, USA
Mov Disord 19:29-35. 2004....
- 25-Hydroxyvitamin D depletion does not exacerbate MPTP-induced dopamine neuron damage in miceE Danielle Dean
Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA
PLoS ONE 7:e39227. 2012..Our data suggest that reducing 25(OH)D serum levels in mice has no effect on the vulnerability of nigral dopaminergic neurons in vivo in this model system of parkinsonism...
- An open study of repetitive transcranial magnetic stimulation in treatment-resistant depression with Parkinson's diseaseCharles M Epstein
Department of Neurology, Emory University School of Medicine, Atlanta, GA 30322, USA
Clin Neurophysiol 118:2189-94. 2007..We studied the effect of left dorsolateral prefrontal rTMS on several different functional domains...
- Association between vitamin B12-containing supplement consumption and prevalence of biochemically defined B12 deficiency in adults in NHANES III (third national health and nutrition examination survey)Marian L Evatt
Department of Neurology, Emory University School of Medicine, Atlanta, GA 30329, USA
Public Health Nutr 13:25-31. 2010..To explore the association between vitamin B(12) (B(12))-containing supplement use, low B(12) concentrations and biochemically defined B(12) deficiency in US adults...
- Potential influences of complementary therapy on motor and non-motor complications in Parkinson's diseaseTheresa A Zesiewicz
Department of Neurology, University of South Florida, Tampa, 33612, USA
CNS Drugs 23:817-35. 2009..Whenever possible, clinicians should ensure that complementary therapy is used appropriately in PD patients without reducing the benefits of dopaminergic therapy...
- Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation--critique and recommendations by movement disorders task force on rating scales for Parkinson's diseaseMarian L Evatt
Section of Movement Disorders, Department of Neurology, Emory University School of Medicine, Atlanta, Georgia 30329, USA
Mov Disord 24:635-46. 2009..Further scale testing in PD among the scales that focus on these symptoms is warranted, and no new scales are needed until the available scales are fully tested clinimetrically...
- Stimulation of the subthalamic nucleus in a patient with Parkinson disease and essential tremorNatividad P Stover
Department of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA
Arch Neurol 62:141-3. 2005..Some patients with PD have coexistent ET, and the identification of a single surgical target to treat both parkinsonian motor symptoms and ET would be of practical importance...
- Movement disorders in pregnancyMarsha S A Smith
Emory University School of Medicine, Atlanta, GA, USA
Neurol Clin 22:783-98. 2004..Therefore, it is in part left to the neurologist to decide on treatment based on the individual patient, clinical judgment, and inferences from animal studies and limited case reports...